BNGO
Bionano Genomics·NASDAQ
--
--(--)
--
--(--)
8.41 / 10
Outperform
Fund flow evaluation: 7.58/10 reflecting robust fund flow characteristics. Constructive overall, block, Small, Medium, Large, and Extra-large trends face headwinds from adverse no significant trends developments, indicating positive money flow direction. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(100.0%) representing 1 analyst views, supported by 9.24 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-24
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate66.7%
What is the analyst consensus for BNGO?
- BNGO holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.41/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
